INTRODUCTION
W ound healing of both oral and dermal wounds proceeds through three complex overlapping phases: inflammation, granulation tissue formation, and matrix formation and remodeling (Clark, 1996; Walsh et al., 1996) . Wound healing involves a series of specific cell populations tightly controlled by a distinct temporal pattern of cellular apoptosis. Apoptosis serves as a crucial control mechanism not only for organ development and growth, but also for the maintenance of tissue integrity in the mature organism (Greenhalgh, 1998) . In general, inflammatory cells undergo apoptosis in early stages of wound healing (Brown et al., 1997) , whereas apoptosis eliminates fibroblasts in later stages (Desmouliere et al., 1997) .
Our previous investigation demonstrated that the constitutive upregulation of secreted frizzled-related protein 1 (SFRP1) contributes to the inhibition of apoptosis in periodontal ligament and dermal fibroblasts (Han and Amar, 2004) . SFRP1 proteins are involved in apoptosis by negatively modulating wingless/int (WNT) signaling by interacting with either WNTs or Frizzled receptors. The WNT family is a group of secreted glycoproteins mediating embryogenesis, organogenesis, and tumorigenesis through the regulation of cell proliferation, differentiation, and apoptosis by increasing the stability and transcriptional activity of ␤-catenin (canonical pathway). By sequestering WNTs, SFRP1 removes the stimulus for ␤-catenin stabilization and mediates various biological processes (Jones and Jomary, 2002; Kawano and Kypta, 2003) . Therefore, SFRP1 may be an appropriate target for the modulation of apoptosis.
Given the role of apoptosis in wound healing, the present study was aimed at determining the role of SFRP1 in dermal vs. palatal wound healing and defining whether the modulation of SFRP1 affects wound-healing outcomes.
MATERIALS & METHODS

Animals and Wound Models
Fifty 8-week-old male CD-1 mice, purchased from the Charles River Laboratories (Boston, MA, USA), were used as models for the comparison of dermal and palatal wounds. An additional 10 age-matched mice were used for the antibody-blocking experiment. All procedures involving animals were approved by the Institutional Animal Care and Use Committee at Boston University Medical Center. Mice were intraperitoneally anesthetized with a ketamine (80 mg/kg) and xylazine (10 mg/kg) mixture. A palatal excisional wound (2.0 mm) was placed anterior to the soft palate, or a scalp excisional wound was placed at the midline between the ears for each mouse. Mice were killed after 0, 3, 7, 10, and 14 days. Five mice per group were used at each time point.
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Blocking SFRP1 with Anti-SFRP1 Antibody
We used anti-SFRP1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) to block the SFRP1 expression in wounded palatal tissues. The control group received IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Five mice per wound group were used. One dose of anti-SFRP1 antibody (30 g) or IgG (30 g) was injected submucosally around the wounded area on 6.5, 8, and 9.5 days (a total dose of 90 g of anti-SFRP1 antibody or IgG).
Mice were killed on the 10th day.
Specimen Preparation
Following the animals' death, the calvarial or palatal bone with intact surrounding tissue was dissected and fixed in cold 4% paraformaldehyde for 24 hrs. After fixation, the specimens were decalcified in cold Immunocal (Decal Corporation, Congers, NY, USA) for 7 days, with the solution changed every day. Cryostat sagittal sections were prepared at a thickness of 5 microns.
Quantitative Histologic Analysis
The distance between the edges of the epithelium and connective tissue of the wound, the area of new connective tissue (defined as the new tissue formed between the wound edges), and the percentage of new connective tissue in the defect were measured in H&Estained sections at the widest part of each wound, with the use of Image-Pro Plus Version 4 software (Media Cybernetics, Silver Spring, MD, USA). We quantified polymorphonuclear neutrophil (PMN) and mononuclear cell infiltrates by identifying their characteristic morphology at 400X magnification. We stained several serial sections adjacent to those H&E-stained with Ly6G for neutrophils and Moma-2 for macrophages at each time-point in both groups. Cell counts obtained with immunostaining or H&E were similar, and the differences were not statistically significant.
In situ Detection of Apoptosis
Apoptotic cells were detected by in situ TUNEL assay by means of an in situ cell death detection kit (Roche Diagnostics, Indianapolis, IN, USA), according to the manufacturer's instructions. At high magnification (400X), TUNEL-positive fibroblasts and inflammatory cells were identified by stringent morphologic characteristics, quantified and presented as percentages of apoptotic cells relative to the total of cell counts in the same field of analysis.
Immunohistochemistry
Immunohistochemical staining was carried out as described previously (Han and Amar, 2004) . At high magnification (400X), SFRP1-positive fibroblasts were quantified; only spindle-shaped cells were counted.
Statistical Analysis
Student's t test was performed for statistical analyses. 
RESULTS
Healing Responses in Palatal and Dermal Groups
In the dermal group, the epithelial gap was dramatically reduced and completely covered the wounds by day 10. In contrast, intact epithelial coverage was not achieved by day 10 in the palatal group (Figs. 1A, 1E ). Connective tissue edges were bridged faster in the dermal group than the palatal group (Figs. 1B, 1E ). Connective tissue healing was complete in dermal wounds on day 10, and the amount of new connective tissue was 1.6-fold more than that of palatal wounds (Fig. 1C) . By day 10, palatal wounds achieved only partial connective tissue coverage (Fig. 1D) .
PMN and mononuclear cell infiltration followed the same timecourses in both groups. However, the PMN and mononuclear cell numbers were significantly lower in the dermal group ( Figs. 2A, 2B ). The inflammatory cell apoptosis peaked on day 3 and then decreased thereafter in both groups. A higher percentage of inflammatory cell apoptosis was observed in the dermal group (Fig. 3A) . The fibroblast apoptosis peaked on day 10 and was sustained until day 14 in the dermal group (Figs. 3B, 3C ). The fibroblast apoptosis in palatal wounds was relatively low when compared with that of dermal wounds.
No detectable SFRP1 expression was observed in the dermal group (Figs. 3D, 3E) . In contrast, SFRP1 was expressed on day 7 and peaked on day 14 in the palatal group. The expression of SFRP1 in palatal wounds, and not in dermal wounds, may suggest its tissue-specific role in wound healing.
Blocking SFRP1 with Anti-SFRP1 Antibody in Palatal Wounds
There were more apoptotic fibroblasts in dermal wounds than in palatal wounds. To investigate the role of SFRP1 in wound healing, we injected anti-SFRP1 antibody into the palatal wound edge. SFRP1 expression was substantially reduced in the anti-SFRP1-injected group (Fig. 4H) . A reduction in epithelial and connective tissue gaps (Fig. 4A) , an increase in new connective tissue formation (Figs. 4B, 4C) , a lower inflammatory cell infiltrate (Figs. 4D, 4E) , as well as an increase in fibroblast apoptosis (Fig. 4G) , were observed in the anti-SFRP1 antibody-injected group compared with those of the palatal group on day 10 (uninjected group). There was no significant difference in inflammatory cell apoptosis in both groups (Fig. 4F ). IgG-injected mice behaved similarly to uninjected mice, with no statistical difference in both groups. No statistical differences were observed when the anti-SFRP1 antibody-injected group was compared with IgG-injected mice or with uninjected mice (data not shown). 
